Not yet recruiting NCT06548178
Phase II Interventional China
HER2-positive Breast Cancer
Not yet recruiting NCT06547476
Phase II Interventional —
Breast Cancer
Recruiting NCT06544577
— Observational China
ESR1 Gene Mutation · Advanced Breast Cancer · Safety
Not yet recruiting NCT06544668
— Observational China
Breast Cancer · Bone Metastases
Recruiting NCT06547853
No phase Interventional Brazil
Breast Cancer Female · Exercise
Not yet recruiting NCT06494865
— Observational —
Breast Cancer
Recruiting NCT06541587
No phase Interventional Taiwan
Breast Cancer · Chemotherapy · Virtual Reality
Recruiting NCT04282031
Phase I / Phase II Interventional China
Advanced Solid Tumor · HR+/HER2- Breast Cancer
Not yet recruiting NCT06539559
Phase II Interventional China
Breast Neoplasms · Neoplasm Metastasis · Drug Therapy
Recruiting NCT06056583
Phase IV Interventional United States
Postpartum · Lactation · Drugs in Breast Milk
Recruiting NCT05259059
— Observational China
Breastfeeding · Infant Development
Recruiting NCT04679454
No phase Interventional Italy
Breast Cancer
Not yet recruiting NCT06537674
— Observational —
HER2+ Breast Cancer
Recruiting NCT06387628
Phase II Interventional China
TNBC - Triple-Negative Breast Cancer
Not yet recruiting NCT06531486
Phase I / Phase II Interventional —
Solid Tumor · Ovarian Cancer · Breast Cancer
Enrolling by invitation NCT06531135
No phase Interventional Taiwan
Breast Cancer Female
Not yet recruiting NCT06530082
Phase I Interventional —
Breast Neoplasms
Recruiting NCT03577197
— Observational Netherlands
Advanced Breast Cancer · Metastatic Breast Cancer
Recruiting NCT06508216
Phase I / Phase II Interventional France
Breast Cancer
Recruiting NCT06236269
Phase II Interventional Spain
Breast Cancer Stage IV
Not yet recruiting NCT06510465
Phase II Interventional China
Breast Cancer
Not yet recruiting NCT06507033
No phase Interventional —
Breast Cancer Related Lymphedema
Recruiting NCT04353557
— Observational China
Breast Cancer
Not yet recruiting NCT06499168
— Observational —
Locally Advanced Breast Cancer
Not yet recruiting NCT06497322
No phase Interventional Germany
Breast Cancer · Triple Negative Breast Cancer
Not yet recruiting NCT05848856
— Observational United States
Breast Cancer Risk · Cardiovascular Disease Risk · Cardiometabolic Risk
Not yet recruiting NCT06435104
Phase II Interventional China
Early Breast Cancer
Not yet recruiting NCT06489821
No phase Interventional —
Metastatic Breast Cancer · Oligoprogression
Recruiting NCT05549024
Early Phase I Interventional China
Breast Cancer · Prostate Cancer · Brain Tumor
Recruiting NCT05635487
Phase II Interventional China
HER2-positive Breast Cancer
Not yet recruiting NCT06483386
Phase II Interventional —
Breast Cancer
Enrolling by invitation NCT06481956
Phase II Interventional China
HER2-positive Advanced Breast Cancer
Recruiting NCT04531696
No phase Interventional Belgium
Breast Cancer · Hereditary Diseases
Recruiting NCT04790305
Phase IV Interventional China
Carcinoma Breast · Triple-negative Breast Cancer · Invasive Ductal Carcinoma, Breast
Recruiting NCT04135586
No phase Interventional Spain
Physical Exercise
Not yet recruiting NCT06475066
No phase Interventional China
Breast Cancer
Not yet recruiting NCT06475443
Phase II Interventional —
Metastatic Breast Cancer in the Brain
Not yet recruiting NCT06454214
— Observational —
Human Breast Tissues
Recruiting NCT06472583
Phase II Interventional Poland
Breast Cancer
Not yet recruiting NCT06470633
Phase II Interventional —
Breast Cancer · HR+/HER2- Breast Cancer
Recruiting NCT05216900
No phase Interventional Netherlands
Breast Cancer
Not yet recruiting NCT06462079
Phase II Interventional —
Brain Metastasis
Recruiting NCT05720260
Phase II Interventional Taiwan
Premenopausal Breast Cancer · Metastatic Breast Cancer · ER Positive Breast Cancer
Recruiting NCT06447623
Phase III Interventional China
Advanced Breast Cancer · HR+/HER2- Breast Cancer
Recruiting NCT06345534
No phase Interventional Belgium
Cancer, Breast
Recruiting NCT04540692
Phase III Interventional Brazil
Breast Cancer
Recruiting NCT05460975
— Observational South Korea
Breast Cancer · Screening
Not yet recruiting NCT06422949
No phase Interventional Italy
Breast Cancer · Neuropathy;Peripheral
Recruiting NCT03815890
Phase II Interventional Netherlands
Breast Cancer
Recruiting NCT05851053
— Observational Netherlands
Neoplasm, Breast · Heart Failure · Cardiotoxicity
Enrolling by invitation NCT06429995
— Observational Netherlands
Breast Cancer
Recruiting NCT06389006
Phase II Interventional China
Breast Cancer
Recruiting NCT06426810
No phase Interventional South Korea
Breast Cancer
Recruiting NCT06425874
— Observational China
Breast Cancer · Surgery · Quality of Life
Not yet recruiting NCT06424054
No phase Interventional —
Breast Cancer · eHealth · Symptom Monitoring
Not yet recruiting NCT06418139
— Observational —
Non-Metastatic Breast Carcinoma
Recruiting NCT06313086
Phase III Interventional China
HER2-positive Breast Cancer
Recruiting NCT06214598
No phase Interventional Serbia
Breast Cancer
Recruiting NCT02926729
No phase Interventional United States
Breast Cancer
Recruiting NCT05730608
No phase Interventional Norway
Breast Cancer Female · Breast Cancer Recurrent
Not yet recruiting NCT06407310
Phase II Interventional —
Triple Negative Breast Cancer
Not yet recruiting NCT06404736
Phase II Interventional China
Early Breast Cancer · Neoadjuvant Therapy · TNBC, Triple Negative Breast Cancer
Recruiting NCT06404697
Phase II Interventional China
Breast Cancer
Not yet recruiting NCT06404463
Phase II Interventional —
Early Breast Cancer · Neoadjuvant Therapy · HR+HER2- Breast Cancer
Recruiting NCT06401304
— Observational Australia, Sweden +1
Breast Cancer · Breast Carcinoma in Situ · Breast Cancer Invasive
Not yet recruiting NCT06383663
No phase Interventional —
Breast Cancer · Ipsilateral Supraclavicular Lymph Node Metastasis
Recruiting NCT06385990
Phase II Interventional China
Triple Negative Breast Neoplasms
Not yet recruiting NCT06381557
Phase IV Interventional —
Cancer-related Fatigue
Not yet recruiting NCT06339281
Phase II Interventional —
Advanced Breast Cancer
Not yet recruiting NCT06372418
No phase Interventional —
Malnutrition, Infant · Breastfeeding, Exclusive
Recruiting NCT02897700
Phase I Interventional China
Breast Cancer
Not yet recruiting NCT06371807
Phase II Interventional Portugal
Early Breast Cancer · Triple Negative Breast Cancer
Recruiting NCT04603209
— Observational United States
Early-stage Breast Cancer · Breast Carcinoma in Situ · Breast Neoplasms
Recruiting NCT06149130
Phase II Interventional China
Breast Cancer
Recruiting NCT05800132
No phase Interventional France
Breast Cancer
Recruiting NCT06341621
Phase III Interventional China
Breast Cancer
Not yet recruiting NCT06354114
Phase II Interventional China
Advanced Breast Cancer
Recruiting NCT06336070
No phase Interventional Spain
Breast Cancer Female · Cardiometabolic Syndrome · Metabolism Disorder, Lipid
Recruiting NCT06334471
— Observational South Korea
Breast Cancer
Recruiting NCT06341894
Phase II Interventional China
Early Breast Cancer
Recruiting NCT06340516
No phase Interventional Sweden
Cardiotoxicity · Breast Cancer · Treatment Side Effects
Not yet recruiting NCT05986071
Phase I / Phase II Interventional France
Breast Cancer
Recruiting NCT06298084
Phase I / Phase II Interventional France
Breast Cancer Metastatic · HER2-positive Metastatic Breast Cancer · HER2 Low Breast Carcinoma
Not yet recruiting NCT06338644
— Observational —
Hormone-receptor-positive Breast Cancer · Human Epidermal Growth Factor 2 Negative Carcinoma of Breast · Metastatic Breast Cancer
Recruiting NCT06330012
No phase Interventional South Korea
HER2-positive Breast Cancer
Recruiting NCT06330870
No phase Interventional South Korea
Breast Cancer · Brain Metastasis
Recruiting NCT05433753
— Observational Japan
HER2-positive Breast Cancer
Recruiting NCT05861271
Phase II Interventional China
Breast Cancer Stage I
Recruiting NCT04383275
Phase II Interventional China
Breast Cancer
Recruiting NCT06314906
Phase III Interventional China
Electroacupuncture · Olanzapine-contained Four-drug Antiemetic · Nausea and Vomiting
Recruiting NCT06321653
— Observational Italy
Arm Lymphedema · Breast Cancer · Radiotherapy Side Effect
Recruiting NCT06319157
No phase Interventional China
Breast Neoplasms
Recruiting NCT06227117
Phase II Interventional China
Breast Cancer
Recruiting NCT06315868
— Observational Italy
Breast Cancer · Organoids
Recruiting NCT06313463
Phase III Interventional China
Breast Neoplasms
Recruiting NCT05979532
— Observational Netherlands
Breast Feeding · Milk, Human
Not yet recruiting NCT06308939
Phase II Interventional China
Metastatic Breast Cancer
Recruiting NCT06202261
Phase I / Phase II Interventional China
Metastatic Breast Cancer · Recurrent Breast Cancer · Advanced Malignancies
Not yet recruiting NCT05370300
— Observational United States
Breast Cancer · Breast Cancer Female
Recruiting NCT05789901
No phase Interventional Canada
HIV Infections · Breast Cancer · Pediatric Emergency Medicine